COGNITION THERAPEUTICS INC

Profile

Company Names

COGNITION THERAPEUTICS INC
COGNITION THERAPUTICS INC

Addresses

2403 SIDNEY STREET, SUITE 261, PITTSBURGH, PA 15203

Phone Numbers

412-770-1621

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$34,884,437.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2018-11-15 
$1,646,868.00 
$8,000,000.00 
$6,353,132.00 
Debt 
7
2018-03-08 
$2,409,575.00 
$5,000,000.00 
$2,590,425.00 
Debt 
6
2016-11-18 
$4,176,324.00 
$6,500,000.00 
$2,323,676.00 
Equity 
5
2016-03-21 
$3,470,072.00 
$4,500,000.00 
$1,029,928.00 
Debt 
4
2014-03-20 
$15,834,018.00 
$16,568,545.00 
$734,527.00 
Equity 
3
2012-12-20 
$3,023,735.00 
$3,500,000.00 
$476,265.00 
Debt 
2
2011-12-05 
$1,823,845.00 
$3,000,000.00 
$1,176,155.00 
Equity 
1
2010-12-17 
$2,500,000.00 
$2,500,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARK 
 
BREEDLOVE 
DIRECTOR
SUSAN 
 
CATALANO 
EXECUTIVE OFFICER, DIRECTOR
FRANZ 
F. 
HEFTI 
DIRECTOR
KENNETH 
 
MOCH 
EXECUTIVE OFFICER, DIRECTOR
KENNETH 
I. 
MOCH 
EXECUTIVE OFFICER, DIRECTOR
HAROLD 
 
SAFFERSTEIN 
EXECUTIVE OFFICER, DIRECTOR
HAROLD 
T. 
SAFFERSTEIN 
EXECUTIVE OFFICER, DIRECTOR
IRWIN 
 
SCHER 
DIRECTOR
PEGGY 
 
WALLACE 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-11-15 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-03-08 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-18 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-18 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-03-21 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-03-20 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-03-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-03-20 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-12-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-12-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-05 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2010-12-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#